Trial Information
Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia
Inclusion Criteria:
- patients with core binding factor positive acute myeloid leukemia
- 18 years or older
- patients were treated with standard chemotherapy
- patients with available medical record and stored bone marrow specimen at time of
diagnosis
Exclusion Criteria:
- no definive criteria
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
response rate
Outcome Time Frame:
within 1 month after enrollment
Safety Issue:
No
Principal Investigator
Dong Hwan Kim, M.D.,Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Division of Hematology and Oncology/Samsung Medical Center
Authority:
South Korea: Institutional Review Board
Study ID:
2009-10-069
NCT ID:
NCT01066286
Start Date:
February 2010
Completion Date:
Related Keywords:
- Myeloid Leukemia
- genome wide SNP-array
- micro-cytogenetic lesion
- KIT mutation
- core binding factor
- acute myeloid leukemia
- The Approval status was changed from Pending to Approved.
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid